Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Hyeyoung Yang, Seo Ree Kim, Myeong Jun Song
Clin Mol Hepatol. 2016;22(4):499-502.   Published online 2016 Nov 25     DOI: https://doi.org/10.3350/cmh.2016.0016
Citations to this article as recorded by Crossref logo
Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease
Kyle A. Davis, Charles R. Puleo, Alexander J. Kovalic, Sarah A. Nisly
Thrombosis Research.2019; 176: 27.     CrossRef
Direct Oral Anticoagulants in Chronic Liver Disease
Taylor D. Steuber, Meredith L. Howard, Sarah A. Nisly
Annals of Pharmacotherapy.2019; 53(10): 1042.     CrossRef
Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants
Matthew Wu, Michael Schuster, Micheal Tadros
Journal of Clinical and Translational Hepatology.2019; 7(X): 1.     CrossRef
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
Mariella Faccia, Maria Elena Ainora, Francesca Romana Ponziani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Maurizio Pompili, Maria Assunta Zocco
World Journal of Gastroenterology.2019; 25(31): 4437.     CrossRef
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
Dawid T. Janczak, Malgorzata K. Mimier, Robert D. McBane, Patrick S. Kamath, Benjamin S. Simmons, Dalene M. Bott-Kitslaar, Charles J. Lenz, Emily R. Vargas, David O. Hodge, Waldemar E. Wysokinski
Mayo Clinic Proceedings.2018; 93(1): 40.     CrossRef
Clinical significance of small-bowel villous edema in patients with liver cirrhosis: A capsule endoscopy study
Ichiro Otani, Shiro Oka, Shinji Tanaka, Akiyoshi Tsuboi, Sayoko Kunihara, Yuko Nagaoki, Hiroshi Aikata, Kazuaki Chayama
Journal of Gastroenterology and Hepatology.2018; 33(4): 825.     CrossRef
Current approaches to challenging scenarios in myeloproliferative neoplasms
Eran Zimran, Ronald Hoffman, Marina Kremyanskaya
Expert Review of Anticancer Therapy.2018; 18(6): 567.     CrossRef
Timing of anticoagulation for portal vein thrombosis in liver cirrhosis: An Italian internist’s perspective
Nicoletta Riva, Walter Ageno
Journal of Translational Internal Medicine.2018; 6(1): 6.     CrossRef
Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis
P. Priyanka, J. T. Kupec, M. Krafft, N. A. Shah, G. J. Reynolds
International Journal of Hepatology.2018; 2018: 1.     CrossRef
Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician
Stefania Basili, Daniele Pastori, Valeria Raparelli, Francesco Violi
Therapeutic Advances in Gastroenterology.2018; 11: 175628481879356.     CrossRef